# Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers

> **NCT04281758** · PHASE1 · COMPLETED · sponsor: **PepsiCo Global R&D** · enrollment: 16 (actual)

## Conditions studied

- Plasma Caffeine Concentration

## Interventions

- **OTHER:** Beverage

## Key facts

- **NCT ID:** NCT04281758
- **Lead sponsor:** PepsiCo Global R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-13
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04281758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04281758, "Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04281758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*